The rate of comorbid depression and medical illness varies from 10 to 40%. Over the years, there has been a paucity of studies completed despite the importance of knowing which antidepressants are the most effective and safest to use in comorbid states. In this review, focus is placed on disorders in these important areas: cardiovascular disease, neurological disorders, diabetes mellitus and cancer. Cardiovascular disease complications can be related in many cases to platelet clumping produced by medications; reductions in morbidity can be achieved by reducing platelet adhesiveness. Specific results have shown sertraline administration to be safe in the post myocardial infarction (MI) state. This is a time of depression-induced increases of 200-300% in mortality. Evidence for safe administration of bupropion, as well as the selective serotonin re-uptake inhibitors (SSRIs) fluoxetine and paroxetine, is also available. The appearance of major depression and diabetes mellitus has been successfully treated with fluoxetine, sertraline and nortriptyline (NTI), however, NTI may lead to a worsening of glucose indices due to its noradrenergic specificity. Regarding neurologic disorders, there is controlled data showing the safety and efficacy of citalopram, sertraline and fluoxetine in post stroke depression. Parkinson's disease has been associated frequently with depression, as might be expected from its characteristic dopamine deficient state. For perhaps the same reason, the agents that can block re-uptake of dopamine i.e., tricyclic antidepressants (TCAs), have been effective in comorborbid depression with Parkinson's disease. In dementia, there is a paucity of information on new agents. However, double-blind data seems to show efficacy for sertraline, paroxetine and citalopram. There are few studies of cancer-related depression treated in a controlled fashion with antidepressants; imipramine, amitriptyline, fluoxetine, paroxetine, mirtazapine and mianserin (not available in the USA) all have support from some published studies.
In recent decades, a focus on the most critical and fundamental concepts has proven highly advantageous to students and educators in many science disciplines. Pharmacology, unlike microbiology, biochemistry, or physiology, lacks a consensus list of such core concepts.Experimental Approach: We sought to develop a research-based, globally relevant list of core concepts that all students completing a foundational pharmacology course should master. This two-part project consisted of exploratory and refinement phases.The exploratory phase involved empirical data mining of the introductory sections of five key textbooks, in parallel with an online survey of over 200 pharmacology educators from 17 countries across six continents. The refinement phase involved three Delphi rounds involving 24 experts from 15 countries across six continents.
Background and Purpose: In recent decades, a focus on the most critical
and fundamental concepts has proven highly advantageous to students and
educators in many science disciplines. Pharmacology, unlike
microbiology, biochemistry or physiology, lacks a consensus list of such
core concepts. Experimental approach: We sought to develop a
research-based, globally relevant list of core concepts that all
students completing a foundational pharmacology course should master.
This two-part project consisted of exploratory and refinement phases.
The exploratory phase involved empirical data mining of the introductory
sections of five key textbooks, in parallel with an online survey of
over 200 pharmacology educators from 17 countries across six continents.
The refinement phase involved three Delphi rounds involving 24 experts
from 15 countries across six continents. Key Results: The exploratory
phase resulted in a consolidated list of 74 candidate core concepts. In
the refinement phase, the expert group produced a consensus list of 25
core concepts of pharmacology. Conclusion and Implications: This list
will allow pharmacology educators everywhere to focus their efforts on
the conceptual knowledge perceived to matter most by experts within the
discipline. Next steps for this project include defining and unpacking
each core concept and developing resources to help pharmacology
educators globally teach and assess these concepts within their
educational contexts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.